14.4 C
London
Sunday, August 20, 2017
Home Tags Fraud

Tag: Fraud

Marcus Hutchins, the researcher who stopped WCry, complained his code was lifted.
[LONDON, UK: 17th August 2017] Xceed Group, an IT change consultancy, is delighted to announce its strategic partnership with First Performance Global, a leading financial technology company, to bring an innovative cards engagement platform to the UK, Europe and beyond.The partnership combines First Performance Globalrsquo;s breakthrough platform with Xceed Grouprsquo;s IT change and transformational capabilities, enabling card issuers in the UK and Europe, Middle East and Africa (EMEA) regions to reduce fraud and operational costs,... Source: RealWire
Extension that surreptitiously steals bank passwords uploaded twice in 17 days.
Google has removed the Interface Online Chrome extension from the Chrome Web Store.

The plugin was used by criminals in Brazil to target corporate users with the aim of stealing banking credentials.
Judge says LinkedIn's reading of hacking law would have troubling consequences.
ThreatMetrix's second-quarter 2017 cyber-crime report reveals the latest fraud trends, with attackers taking advantage of WannaCry fears to further their aims.
Driver allegedly "suddenly and inexplicably veered through four lanes of traffic."
Federal prosecutors charged two Iranian nationals with identity theft and use of stolen credit card numbers as well as threatening to expose the breach to one of the victim's customers.
The charges stem from an alleged Ponzi-like scheme.
$9.25 monthly subsidy for mobile service would be eliminated by Republican bill.

DDoS attacks in Q2 2017

The second quarter quite clearly showed that the DDoS-attack threat is perceived rather seriously.
Some companies were prepared to pay cybercriminals literally after their first demand without waiting for the attack itself.

This set off a whole new wave of fraud involving money extortion under threat of a DDoS attack, also known as “ransom DDoSrdquo;.
Colorful closing arguments cap weird trial for the ex-pharmaceutical exec.